Vegamour
Plant-based hair growth and wellness brand sold direct and through Sephora.
On the record
Checkpoint: Outcome of pending false-advertising class action and NAD marketing claim review
The call
Vegamour built real reach through Sephora and DTC subscribers, but shrinking headcount, stalled funding, and Nutrafol's lead point to a brand fighting to hold its footing.
Vegamour sells vitamins and shampoos meant to help hair grow, sold online and at Sephora stores. It is easy for bigger companies like Unilever (which owns Nutrafol) to copy the formula and spend more on ads, and neither Vegamour nor Unilever can prove their products work better than FDA-approved drugs like Rogaine because the government has not approved them as medicines. The company cut its staff in half between 2024 and 2026 and has not raised new investor money in five years, which usually means trouble ahead, either a fire sale, a forced deal, or a bankruptcy.
Why
01
AI pressure: AI-generated search and review content plus AI ad-targeting tools. AI summaries and comparison content can bypass Vegamour's SEO and cut into search-driven discovery and ad efficiency. Could AI do the core job? Only partly.
02
Bigger players: Nutrafol (owned by Unilever). Nutrafol ranks first with dermatologists and has Unilever's budget and distribution behind it while Vegamour cuts staff. Could a giant copy it? Yes, easily.
03
What protects it. Sephora shelf space and an existing subscriber base give Vegamour a distribution foothold rivals still have to buy.
What would change this call
Vegamour announces a recapitalization, down-round, or sale within 6 to 12 months. Would confirm financial distress rather than a growth pause.
Vegamour headcount trend past Q3 2026 (currently ~73). Multiple quarters of growth would signal stabilization; further decline confirms retrenchment.
Resolution of the false-advertising class action filed around 2024. An adverse judgment could force further changes to marketing claims and costs.
Vegamour headcount trend past Q3 2026 (currently ~73). Multiple quarters of growth would signal stabilization; further decline confirms retrenchment.
Resolution of the false-advertising class action filed around 2024. An adverse judgment could force further changes to marketing claims and costs.
Key numbers
- Headcount fell from 140 to 73 employees
- No new institutional funding since $80M round
- Trustpilot rating 3.1/5 vs Nutrafol's 3.4/5
Named risks
- Headcount nearly halved from ~140 (Feb 2024) to ~73 (Jun 2026) with no new capital since 2021.
- Active false-advertising class action filed 2024 over hair, lash, brow regrowth claims.
- No FDA-approved drug claims, unlike Rogaine/Propecia, leaving marketing exposed to regulatory challenge.
- AI-generated comparison content substituting for organic search discovery in DTC acquisition funnel.
- Prior BBB/NAD challenge already forced retraction of anti-gray serum claims in 2023.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| Nutrafol (Unilever) | losing to | Ranked No.1 in 2025 U.S. News dermatologist/pharmacist survey while Vegamour was not cited as category leader |
| Rogaine/Propecia (FDA-approved incumbents) | losing to | Only FDA-approved hair-loss treatments as of n.d., setting a regulatory bar Vegamour's cosmetic claims cannot meet |
| Hims & Hers telehealth platforms | contesting | Publishes comparison content positioning itself against both Vegamour and Nutrafol as of April 2025 |
| Living Proof, Briogeo, OUAI | contesting | Listed as direct competitors in PitchBook's 2026 Vegamour company profile |
Questions people ask
- Is Vegamour profitable in 2026?
- No public profitability figures exist. Vegamour is private with no disclosed financials; headcount fell from about 140 employees in February 2024 to about 73 by June 2026, a signal more consistent with cost-cutting than profitable growth.
- Has Vegamour raised new funding recently?
- No. Vegamour's last disclosed institutional round was $80M in growth equity from General Atlantic on April 13, 2021. As of June 2026, no new institutional capital has been reported in over five years.
- Who is Vegamour's biggest competitor?
- Nutrafol, owned by Unilever since 2022, is Vegamour's most-cited rival. A 2025 U.S. News survey of dermatologists and pharmacists ranked Nutrafol No. 1 for hair-growth vitamins; Vegamour was not named a category leader.
- Could AI replace Vegamour's business?
- Vegamour's physical products and Sephora retail placement are not directly AI-substitutable, but AI-generated comparison and review content is already replacing organic search discovery for its DTC customer-acquisition funnel as of 2025-2026.
- Who owns Vegamour?
- Vegamour remains privately held, founded in 2016 by Daniel 'Dan' Hodgdon who is Founder/Chair. General Atlantic holds a minority stake from its $80M April 2021 investment; actress Nicole Kidman is cited as an individual investor.
- Does Vegamour face any lawsuits?
- Yes. A proposed false-advertising class action over hair, lash, and brow regrowth claims was filed around 2024, and a 2023 BBB National Programs/NAD challenge forced Vegamour to voluntarily drop certain anti-gray-serum ad claims.
Timeline
- 2026-07-23BMJ study links GLP-1 drugs like Ozempic and Mounjaro to hair loss, a potential demand tailwind for the category
- 2026-06-20Crustdata reports Vegamour headcount at about 73, down from a 2024 peak, Growth Score 31 of 100
- 2025-08-04Architizer profile describes completed Vegamour headquarters build-out in Capitol Milling Complex, downtown LA
- 2025-07-14Vegamour launches GRO+ Advanced Hair Growth and Density Supplements at $88 per month subscription
- 2024-05-06Proposed consumer class action alleging false advertising over regrowth claims filed against Vegamour
- 2024-02Vegamour headcount peaks at approximately 140 employees
- 2023-10-10ADA web-accessibility lawsuit filed against Vegamour by blind plaintiff Barbara Blejewski
- 2023-04-04TINA.org sends warning letter urging Vegamour to align marketing with FDA and FTC rules
- 2022-05-30Unilever acquires majority stake in Nutrafol, Vegamour's chief rival
- 2021-04-13Vegamour announces $80M growth-equity round led by General Atlantic
Revision history
23 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Clean Hair Brand Vegamour Announces $80 Million In Private Equity Funding (2021-04-13)
- VEGAMOUR - Headcount, Funding & Open Jobs (2026-06-20)
- VEGAMOUR Stock Price, Funding, Valuation, Revenue (2022-05-30)
- VEGAMOUR Company Profile: Financials, Valuation, and Growth (2024-03-14)
- Vegamour Offices by Studio Murnane (2025-08-04)
- Management and Employees List
- U.S. News: Best OTC Skincare Products 2025-2026
- How Does Rennora Beauty Compare? (2026-03-30)
- Vegamour Lawsuit Allegations (2024-05-06)
- Vegamour Lawsuit: Essential Facts and Developments (2023-10-10)
- TINA.org letter to Vegamour
- Vegamour Discontinues Certain Claims for Gro Ageless Hair Serum (2025-01-12)